Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Pharmaceutics|October 27, 2022
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of RasagilinePablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, et al.
Drugs in R&D|August 2, 2022
Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy VolunteersManuel Román Martinez, Eva García Aguilar, Samuel Martin Vílchez, et al.
International Journal of Antimicrobial Agents|July 8, 2019
Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish populationIrene Dapía, Irene García, Jose Carlos Martinez, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drugMichel Pieren, Ana Abáigar Gutiérrez-Solana, Rosa María Antonijoan Arbós, et al.
Human Vaccines & Immunotherapeutics|February 17, 2026
Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation studyIsabel Leroux-Roels, Ilse De Coster, Alberto M Borobia, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trialMurdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2024
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of AgeMurdo Ferguson, Tino F Schwarz, Sebastián A Núñez, et al.
Lung|July 4, 2019
Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural MesotheliomaCarmina Jiménez-Ramírez, Swaantje Casjens, Cuauhtémoc Arturo Juárez-Pérez, et al.
BMC Genomics|May 27, 2010
Genetic structure of the Spanish populationJavier Gayán, José J Galan, Antonio González-Pérez, et al.
International Journal of Medical Sciences|July 17, 2018
Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican PopulationGuadalupe Aguilar-Madrid, Beate Pesch, Emma S Calderón-Aranda, et al.
Pageof 12